Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6436]

Cell surface protein uPAR may hold the key to targeting solid tumours with car t cell therapy

Cell surface protein uPAR may hold the key to targeting solid tumours with car t cell therapy

Vaping likely to cause cancer: New findings

Vaping likely to cause cancer: New findings

An avatar to study paediatric brain cancer

McVie-Veronesi Award: Recognising leaders in improving cancer outcomes in LMICs - call for nominations

McVie-Veronesi Award: Recognising leaders in improving cancer outcomes in LMICs - call for nominations

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Chaos in lymph nodes promotes cancer

Chaos in lymph nodes promotes cancer

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or...

EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive

EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of...

Atezolizumab plus chemo after surgery shows benefit for stage III dMMR colon cancer

Atezolizumab plus chemo after surgery shows benefit for stage III dMMR colon cancer

Advancing colorectal cancer care: Bringing dual immunotherapy and subcutaneous innovation to UK patients

Advancing colorectal cancer care: Bringing dual immunotherapy and subcutaneous innovation to UK patients

More from ecancer